Labat Africa (JSE:LAB) YoY EPS Growth: 227.27% (As of Nov. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Labat Africa YoY EPS Growth?

Labat Africa JSE:LAB YoY EPS Growth is 227.27% as of Nov. 2025. The stock has 5 warning signs investors should review.

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Labat Africa's YoY EPS Growth for the quarter that ended in Nov. 2025 was 227.27%.

Labat Africa's Earnings per Share (Diluted) for the six months ended in Nov. 2025 was R0.04.


Labat Africa YoY EPS Growth Historical Data

* Premium members only.

The historical data trend for Labat Africa's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Labat Africa YoY EPS Growth Chart

Labat Africa Annual Data
Trend Feb14 Feb15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 May23 May24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -614.29 112.30 -283.87 -150.88 72.03

Labat Africa Semi-Annual Data
Aug15 Aug16 Feb17 Aug17 Feb18 Aug18 Feb19 Aug19 Feb20 Aug20 Feb21 Aug21 Feb22 Nov22 May23 Nov23 May24 Nov24 May25 Nov25
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 300.00 67.59 37.50 308.51 227.27

Labat Africa YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Labat Africa's YoY EPS Growth for the fiscal year that ended in May. 2024 is calculated as:

YoY EPS Growth (A: May. 2024 )
=(Earnings per Share (Diluted) (A: May. 2024 )-Earnings per Share (Diluted) (A: May. 2023 ))/ | Earnings per Share (Diluted) (A: May. 2023 ) |
=(-0.04--0.143)/ | -0.143 |
=72.03 %

Labat Africa's YoY EPS Growth for the quarter that ended in Nov. 2025 is calculated as:

YoY EPS Growth (Q: Nov. 2025 )
=(Earnings per Share (Diluted) (Q: Nov. 2025 )-Earnings per Share (Diluted) (Q: Nov. 2024 )) / | Earnings per Share (Diluted) (Q: Nov. 2024 )) |
=(0.036-0.011)/ | 0.011 |
=227.27 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EPS Growth →
What does a YoY EPS Growth of 227.27% mean?
Labat Africa (JSE:LAB) has a YoY EPS Growth of 227.27% as of Nov. 2025. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Labat Africa and its competitors.
Is Labat Africa's YoY EPS Growth too high?
Labat Africa's current YoY EPS Growth is 227.27%.
How does Labat Africa's YoY EPS Growth compare to ZTS and UTHR?
Labat Africa's YoY EPS Growth of 227.27% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EPS Growth for a Drug Manufacturers company?
A good YoY EPS Growth depends on the Drug Manufacturers industry context. However, YoY EPS Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EPS Growth mean?
A high YoY EPS Growth can signal that a stock is expensive relative to its fundamentals. YoY EPS Growth is the percentage change of EPS over the past 12-month. View historical data for Labat Africa and its competitors. Labat Africa's current YoY EPS Growth is 227.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.18, compared to a current price of R0.03 — trading 83.3% below its estimated fair value. The current YoY EPS Growth is 227.27%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EPS Growth calculated?
YoY EPS Growth is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current YoY EPS Growth is 227.27% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Labat Africa Business Description

Other Exchanges LAO:Germany
Address 75 Maude StreetSandown, The Leonardo 14th Floor, Sandown, Johannesburg, GT, ZAF, 1709
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.